Interference by prostaglandin E2 with the phosphaturic effects of nonhormonal agents

T. O. Pitts, Jesus Dominguez, J. B. Puschett

Research output: Contribution to journalArticle

Abstract

The purpose of the present study was to evaluate the ability of prostaglandin (PG) E2 to alter phosphate excretory patterns induced by the nonhormonally mediated phosphaturic maneuvers, bicarbonate loading (BIC), volume expansion (VE) and acetazolamide administration (Az). Acute clearance studies were performed in chronically thyroparathyroid-ectomized dogs. The dosage of PGE2 utilized was free of excretory or hemodynamic effects. After BIC, percentage of phosphate excretion (%EP) increased from 4.8 to 14.0%, (P <.05). In contrast, BIC preceded by PGE2 infusion produced no phosphaturia. Additionally, PGE2 blunted the increases in Na and HCO3 excretion associated with BIC. VE (5-6% b.wt.) increased %EP from 6.0 to 14.2%, (P <.01). However, VE after PGE2 treatment did not result in a phosphaturia. Az increased %EP from 4.7 to 28.5%, P <.02). When PGE2 was infused before Az, %EP rose from 1.9 to 7.1%, (P <.02) in response to Az. However, the increment in %EP over base line was reducted from 23.8 to 3.6% by PGE2 pretreatment (P <.005). PGE2 did not alter the effects of VE or Az on sodium or bicarbonate excretion. Thus, PGE2 blunts or abolishes the phosphaturic effect of each of these maneuvers independent of its action on sodium or bicarbonate transport. We conclude that PGs have a specific action on phosphate transport events induced by certain nonhormonal factors, revealing a hitherto unappreciated role for these agents in modulating tubular reabsorptive processes.

Original languageEnglish (US)
Pages (from-to)601-606
Number of pages6
JournalJournal of Pharmacology and Experimental Therapeutics
Volume230
Issue number3
StatePublished - 1984
Externally publishedYes

Fingerprint

Dinoprostone
Bicarbonates
Familial Hypophosphatemia
Sodium Bicarbonate
Phosphates
Acetazolamide
Hemodynamics
Dogs

ASJC Scopus subject areas

  • Pharmacology

Cite this

Interference by prostaglandin E2 with the phosphaturic effects of nonhormonal agents. / Pitts, T. O.; Dominguez, Jesus; Puschett, J. B.

In: Journal of Pharmacology and Experimental Therapeutics, Vol. 230, No. 3, 1984, p. 601-606.

Research output: Contribution to journalArticle

@article{b448b387fec7451c96c3eee23b85bf6a,
title = "Interference by prostaglandin E2 with the phosphaturic effects of nonhormonal agents",
abstract = "The purpose of the present study was to evaluate the ability of prostaglandin (PG) E2 to alter phosphate excretory patterns induced by the nonhormonally mediated phosphaturic maneuvers, bicarbonate loading (BIC), volume expansion (VE) and acetazolamide administration (Az). Acute clearance studies were performed in chronically thyroparathyroid-ectomized dogs. The dosage of PGE2 utilized was free of excretory or hemodynamic effects. After BIC, percentage of phosphate excretion ({\%}EP) increased from 4.8 to 14.0{\%}, (P <.05). In contrast, BIC preceded by PGE2 infusion produced no phosphaturia. Additionally, PGE2 blunted the increases in Na and HCO3 excretion associated with BIC. VE (5-6{\%} b.wt.) increased {\%}EP from 6.0 to 14.2{\%}, (P <.01). However, VE after PGE2 treatment did not result in a phosphaturia. Az increased {\%}EP from 4.7 to 28.5{\%}, P <.02). When PGE2 was infused before Az, {\%}EP rose from 1.9 to 7.1{\%}, (P <.02) in response to Az. However, the increment in {\%}EP over base line was reducted from 23.8 to 3.6{\%} by PGE2 pretreatment (P <.005). PGE2 did not alter the effects of VE or Az on sodium or bicarbonate excretion. Thus, PGE2 blunts or abolishes the phosphaturic effect of each of these maneuvers independent of its action on sodium or bicarbonate transport. We conclude that PGs have a specific action on phosphate transport events induced by certain nonhormonal factors, revealing a hitherto unappreciated role for these agents in modulating tubular reabsorptive processes.",
author = "Pitts, {T. O.} and Jesus Dominguez and Puschett, {J. B.}",
year = "1984",
language = "English (US)",
volume = "230",
pages = "601--606",
journal = "Journal of Pharmacology and Experimental Therapeutics",
issn = "0022-3565",
publisher = "American Society for Pharmacology and Experimental Therapeutics",
number = "3",

}

TY - JOUR

T1 - Interference by prostaglandin E2 with the phosphaturic effects of nonhormonal agents

AU - Pitts, T. O.

AU - Dominguez, Jesus

AU - Puschett, J. B.

PY - 1984

Y1 - 1984

N2 - The purpose of the present study was to evaluate the ability of prostaglandin (PG) E2 to alter phosphate excretory patterns induced by the nonhormonally mediated phosphaturic maneuvers, bicarbonate loading (BIC), volume expansion (VE) and acetazolamide administration (Az). Acute clearance studies were performed in chronically thyroparathyroid-ectomized dogs. The dosage of PGE2 utilized was free of excretory or hemodynamic effects. After BIC, percentage of phosphate excretion (%EP) increased from 4.8 to 14.0%, (P <.05). In contrast, BIC preceded by PGE2 infusion produced no phosphaturia. Additionally, PGE2 blunted the increases in Na and HCO3 excretion associated with BIC. VE (5-6% b.wt.) increased %EP from 6.0 to 14.2%, (P <.01). However, VE after PGE2 treatment did not result in a phosphaturia. Az increased %EP from 4.7 to 28.5%, P <.02). When PGE2 was infused before Az, %EP rose from 1.9 to 7.1%, (P <.02) in response to Az. However, the increment in %EP over base line was reducted from 23.8 to 3.6% by PGE2 pretreatment (P <.005). PGE2 did not alter the effects of VE or Az on sodium or bicarbonate excretion. Thus, PGE2 blunts or abolishes the phosphaturic effect of each of these maneuvers independent of its action on sodium or bicarbonate transport. We conclude that PGs have a specific action on phosphate transport events induced by certain nonhormonal factors, revealing a hitherto unappreciated role for these agents in modulating tubular reabsorptive processes.

AB - The purpose of the present study was to evaluate the ability of prostaglandin (PG) E2 to alter phosphate excretory patterns induced by the nonhormonally mediated phosphaturic maneuvers, bicarbonate loading (BIC), volume expansion (VE) and acetazolamide administration (Az). Acute clearance studies were performed in chronically thyroparathyroid-ectomized dogs. The dosage of PGE2 utilized was free of excretory or hemodynamic effects. After BIC, percentage of phosphate excretion (%EP) increased from 4.8 to 14.0%, (P <.05). In contrast, BIC preceded by PGE2 infusion produced no phosphaturia. Additionally, PGE2 blunted the increases in Na and HCO3 excretion associated with BIC. VE (5-6% b.wt.) increased %EP from 6.0 to 14.2%, (P <.01). However, VE after PGE2 treatment did not result in a phosphaturia. Az increased %EP from 4.7 to 28.5%, P <.02). When PGE2 was infused before Az, %EP rose from 1.9 to 7.1%, (P <.02) in response to Az. However, the increment in %EP over base line was reducted from 23.8 to 3.6% by PGE2 pretreatment (P <.005). PGE2 did not alter the effects of VE or Az on sodium or bicarbonate excretion. Thus, PGE2 blunts or abolishes the phosphaturic effect of each of these maneuvers independent of its action on sodium or bicarbonate transport. We conclude that PGs have a specific action on phosphate transport events induced by certain nonhormonal factors, revealing a hitherto unappreciated role for these agents in modulating tubular reabsorptive processes.

UR - http://www.scopus.com/inward/record.url?scp=0021285580&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0021285580&partnerID=8YFLogxK

M3 - Article

VL - 230

SP - 601

EP - 606

JO - Journal of Pharmacology and Experimental Therapeutics

JF - Journal of Pharmacology and Experimental Therapeutics

SN - 0022-3565

IS - 3

ER -